首页> 美国卫生研究院文献>BMC Bioinformatics >ODAE: Ontology-based systematic representation and analysis of drug adverse events and its usage in study of adverse events given different patient age and disease conditions
【2h】

ODAE: Ontology-based systematic representation and analysis of drug adverse events and its usage in study of adverse events given different patient age and disease conditions

机译:ODAE:在不同患者年龄和疾病条件下基于不良反应的药物不良事件及其研究中基于本体的系统表示和分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundDrug adverse events (AEs), or called adverse drug events (ADEs), are ranked one of the leading causes of mortality. The Ontology of Adverse Events (OAE) has been widely used for adverse event AE representation, standardization, and analysis. OAE-based ADE-specific ontologies, including ODNAE for drug-associated neuropathy-inducing AEs and OCVDAE for cardiovascular drug AEs, have also been developed and used. However, these ADE-specific ontologies do not consider the effects of other factors (e.g., age and drug-treated disease) on the outcomes of ADEs. With more ontological studies of ADEs, it is also critical to develop a general purpose ontology for representing ADEs for various types of drugs.
机译:背景药物不良事件(AEs)或称为药物不良事件(ADEs)被认为是导致死亡的主要原因之一。不良事件本体(OAE)已被广泛用于不良事件AE表示,标准化和分析。还开发并使用了基于OAE的ADE专用本体,包括用于药物相关性神经病诱导AE的ODNAE和用于心血管药物AE的OCVDAE。但是,这些特定于ADE的本体没有考虑其他因素(例如年龄和药物治疗的疾病)对ADE结果的影响。随着对ADE的更多本体研究,开发用于代表各种类型药物的ADE的通用本体也至关重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号